Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2007 4
2008 1
2009 1
2010 2
2011 4
2012 4
2013 5
2014 9
2015 15
2016 11
2017 13
2018 12
2019 18
2020 14
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 32826324

102 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Severe Renal Disease.
Casal Moura M, Irazabal MV, Eirin A, Zand L, Sethi S, Borah BJ, Winters JL, Moriarty JP, Cartin-Ceba R, Berti A, Baqir M, Thompson GE, Makol A, Warrington KJ, Thao V, Specks U, Fervenza FC. Casal Moura M, et al. J Am Soc Nephrol. 2020 Aug 21:ASN.2019111197. doi: 10.1681/ASN.2019111197. Online ahead of print. J Am Soc Nephrol. 2020. PMID: 32826324
Sequential Therapy for Remission Induction in Severe Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis.
Kant S, Habbach A, Gapud EJ, Manno RL, Gattu R, Seo P, Geetha D. Kant S, et al. Am J Nephrol. 2019;50(5):386-391. doi: 10.1159/000503318. Epub 2019 Oct 8. Am J Nephrol. 2019. PMID: 31593967 Clinical Trial.
Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement.
Geetha D, Specks U, Stone JH, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Fessler BJ, Ding L, Tchao NK, Ikle D, Jepson B, Brunetta P, Fervenza FC; Rituximab for ANCA-Associated Vasculitis Immune Tolerance Network Research Group. Geetha D, et al. J Am Soc Nephrol. 2015 Apr;26(4):976-85. doi: 10.1681/ASN.2014010046. Epub 2014 Nov 7. J Am Soc Nephrol. 2015. PMID: 25381429 Free PMC article. Clinical Trial.
Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
Timlin H, Lee SM, Manno RL, Seo P, Geetha D. Timlin H, et al. Semin Arthritis Rheum. 2015 Aug;45(1):67-9. doi: 10.1016/j.semarthrit.2015.02.005. Epub 2015 Feb 20. Semin Arthritis Rheum. 2015. PMID: 25796088 Free PMC article.
Rituximab for treatment of severe renal disease in ANCA associated vasculitis.
Geetha D, Hruskova Z, Segelmark M, Hogan J, Morgan MD, Cavero T, Eriksson P, Seo P, Manno RL, Dale J, Harper L, Tesar V, Jayne DR. Geetha D, et al. J Nephrol. 2016 Apr;29(2):195-201. doi: 10.1007/s40620-015-0208-y. Epub 2015 May 19. J Nephrol. 2016. PMID: 25986390
Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
Unizony S, Villarreal M, Miloslavsky EM, Lu N, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CM, St Clair EW, Ikle D, Tchao NK, Ding L, Brunetta P, Choi HK, Monach PA, Fervenza F, Stone JH, Specks U; RAVE-ITN Research Group. Unizony S, et al. Ann Rheum Dis. 2016 Jun;75(6):1166-9. doi: 10.1136/annrheumdis-2015-208073. Epub 2015 Nov 30. Ann Rheum Dis. 2016. PMID: 26621483 Free PMC article. Clinical Trial.
Rituximab in relapsing and de novo MPO ANCA-associated vasculitis with severe renal involvement: a case series.
Caroti L, Cirami CL, Di Maria L, Larti A, Carta P, Dervishi E, Farsetti S, Tsalouchos A, Novelli L, Minetti EE. Caroti L, et al. BMC Nephrol. 2019 May 14;20(1):162. doi: 10.1186/s12882-019-1350-x. BMC Nephrol. 2019. PMID: 31088509 Free PMC article.
Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis.
Miloslavsky EM, Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Tchao NK, Viviano L, Ding L, Sejismundo LP, Mieras K, Iklé D, Jepson B, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Stone JH; Rituximab in ANCA-Associated Vasculitis-Immune Tolerance Network Research Group. Miloslavsky EM, et al. Arthritis Rheum. 2013 Sep;65(9):2441-9. doi: 10.1002/art.38044. Arthritis Rheum. 2013. PMID: 23754238 Free PMC article. Clinical Trial.
The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitis.
Berti A, Warner R, Johnson K, Cornec D, Schroeder DR, Kabat BF, Langford CA, Kallenberg CGM, Seo P, Spiera RF, St Clair EW, Fervenza FC, Stone JH, Monach PA, Specks U, Merkel PA; RAVE-ITN Research Group. Berti A, et al. J Autoimmun. 2019 Dec;105:102302. doi: 10.1016/j.jaut.2019.07.001. Epub 2019 Jul 15. J Autoimmun. 2019. PMID: 31320177 Clinical Trial.
Rituximab Versus Cyclophosphamide for Central Nervous System Involvement of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Case Series.
Krishna R, De Giacomi F, Kumar N, Kalina P, Specks U, Baqir M. Krishna R, et al. J Clin Rheumatol. 2019 Sep 13. doi: 10.1097/RHU.0000000000001169. Online ahead of print. J Clin Rheumatol. 2019. PMID: 31567753
102 results
Jump to page
Feedback